Oral Bacteria May Predict Lung Cancer Risk Through Genetic Analysis

This groundbreaking study reveals that specific oral bacteria directly influence lung cancer risk, opening new possibilities for early screening and prevention. Using Mendelian randomization analysis—a method that uses genetic variations to establish causation rather than just correlation—researchers analyzed data from nearly 3,000 individuals to identify which oral microbes truly affect cancer development.

The team discovered three key bacterial relationships: Gemella haemolysans in saliva significantly reduces lung cancer risk by 35-39%, while an unclassified Clostridia species also provides protection. Conversely, certain Prevotella bacteria on the tongue increase cancer risk by 47%. These findings are particularly significant because they establish causation, not just association.

The implications are substantial for clinical practice. Oral microbiome testing could become a simple, non-invasive screening tool for identifying high-risk individuals before symptoms appear. Since lung cancer often goes undetected until advanced stages, early identification through saliva or tongue swabs could dramatically improve outcomes. The research also suggests that targeted interventions to modify oral bacteria composition might prevent cancer development.

These findings align with previous observations that periodontal disease increases lung cancer risk, as Gemella haemolysans is known to suppress harmful oral bacteria associated with gum disease. The study's strength lies in its genetic approach, which eliminates confounding factors that plague observational studies and establishes true causal relationships between specific microbes and cancer risk.